๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD ยท Real-Time Price ยท USD
4.780
-0.090 (-1.85%)
At close: Nov 18, 2026, 4:00 PM EST
4.827
+0.047 (0.99%)
After-hours: Nov 18, 2026, 6:46 PM EST

Ironwood Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
400.3296.15351.41442.74410.6413.75
Revenue Growth
18.09%-15.72%-20.63%7.83%-0.76%6.22%
Gross Profit
305.72201.02239.99337.95366.33343.35
Operating Income
251.72118.9596.36195.84250.34232.22
Net Income
149.6324.020.88-1,002175.07528.45
Earnings Per Share
0.910.150.01-6.450.963.21
EPS Growth
412.03%2583.01%---69.98%386.36%

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
289.34341.22432.99402.79404.65
Rest of World
6.8110.199.747.89.1
Total
296.15351.41442.74410.6413.75

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
86.38215.4688.5692.15656.2620.13
Total Debt
336.21597.8599.48715.54415.92475.8
Net Cash (Debt)
-249.83-382.35-510.92-623.38240.29144.33
Net Cash Growth
----66.49%-
Net Cash Per Share
-1.53-2.35-3.19-4.011.290.88

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
205.37127.04103.55183.43273.76261.9
Capital Expenditures
0-0.03-0.14-0.27-0.14-0.27
Free Cash Flow
205.37127.01103.41183.15273.63261.63
Free Cash Flow Growth
203.59%22.82%-43.54%-33.06%4.58%56.67%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
76.37%67.88%68.29%76.33%89.22%82.98%
Operating Margin
62.88%40.17%27.42%44.23%60.97%56.12%
Pretax Margin
56.70%23.65%18.55%-214.14%61.48%48.50%
Profit Margin
37.38%8.11%0.25%-226.37%42.64%127.72%
FCF Margin
51.31%42.89%29.43%41.37%66.64%63.23%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
5.2722.83805.60-10.863.61
Forward PE
3.407.8413.4214.1411.248.43
P/FCF Ratio
3.854.326.869.756.957.29
PS Ratio
1.971.852.024.034.634.61